Acute promyelocytic leukemia (APL) represents about 10% of acute myeloid leukemias and is characterized by a specific translocation between chromosomes 15 and 17, resulting in the fusion of the ...
Arsenic trioxide (ATO) mediates PML-RARA (promyelocytic leukemia–retinoic acid receptor-α) oncoprotein degradation via the proteasome pathway and this degradation appears to be critical for achieving ...
Rose Ann Padua, Jerome Larghero, Marie Robin, Carol le Pogam, Marie-Helene Schlageter, Sacha Muszlak, Jan Fric, Robert West, Philippe Rousselot, Thi Hai Phan, Liesbeth Mudde, Helene Teisserenc, ...
Acute promyelocytic leukemia (APL) is a rare and aggressive form of leukemia, a cancer that affects blood cells. It is caused by a genetic mutation where two genes, PML and RARA, mistakenly fuse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results